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Porphyromonas gingivalis gingipains cause defective
macrophage migration towards apoptotic cells and
inhibit phagocytosis of primary apoptotic neutrophils
Sowmya A Castro1, Russell Collighan1, Peter A Lambert1, Irundika HK Dias1, Parbata Chauhan1, Charlotte E Bland1, Ivana Milic1,
Michael R Milward2, Paul R Cooper2 and Andrew Devitt*,1
Periodontal disease is a prevalent chronic inflammatory condition characterised by an aberrant host response to a pathogenic
plaque biofilm resulting in local tissue damage and frustrated healing that can result in tooth loss. Cysteine proteases (gingipains)
from the key periodontal pathogen Porphyromonas gingivalis have been implicated in periodontal disease pathogenesis by
inhibiting inflammation resolution and are linked with systemic chronic inflammatory conditions such as rheumatoid arthritis.
Efficient clearance of apoptotic cells is essential for the resolution of inflammation and tissue restoration. Here we sought to
characterise the innate immune clearance of apoptotic cells and its modulation by gingipains. We examined the capacity of
gingipain-treated macrophages to migrate towards and phagocytose apoptotic cells. Lysine gingipain treatment of macrophages
impaired macrophage migration towards apoptotic neutrophils. Furthermore, lysine gingipain treatment reduced surface
expression levels of CD14, a key macrophage receptor for apoptotic cells, which resulted in reduced macrophage interactions with
apoptotic cells. Additionally, while apoptotic cells and their derived secretome were shown to inhibit TNF-α-induced expression by
P. gingivalis lipopolysaccharide, we demonstrated that gingipain preparations induced a rapid inflammatory response in
macrophages that was resistant to the anti-inflammatory effects of apoptotic cells or their secretome. Taken together, these data
indicate that P. gingivalis may promote the chronic inflammation seen in periodontal disease patients by multiple mechanisms,
including rapid, potent gingipain-mediated inflammation, coupled with receptor cleavage leading to defective clearance of
apoptotic cells and reduced anti-inflammatory responses. Thus, gingipains represent a potential therapeutic target for intervention
in the management of chronic periodontal disease.
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Tightly regulated tissue homeostasis is an essential physio-
logical process, which is maintained through a fine balance of
cell proliferation, cell differentiation and cell death. The
process of apoptosis that occurs during an inflammatory
response supports the resolution of inflammation by the
secretion of anti-inflammatory cytokines and pro-resolving
molecules, which block further inflammatory cell infiltration
and promotes recruitment of phagocytes which restore tissue
homeostasis. Recent work demonstrates that a variety of
factors promote the clearance of apoptotic cells (AC) and that
these mediate different stages within a complex multistage
process of apoptotic cell clearance by professional Apoptotic
cell-derived extracellular vesicles and soluble factors (collec-
tively known as the apoptotic cell secretome) can promote
recruitment of phagocytes to sites of cell death whereupon
ligand–receptor interactions enable tethering and engulfment
of cell corpses.3–6 Failure in any one of the stages of AC
clearance can lead to inflammatory disease as a consequence
of secondary necrosis of AC, due to release of intracellular
antigens and immune stimulation.7–9
In the oral cavity, gingival tissues are exposed to awide range
of microorganisms. Evidence indicates that local tissue
apoptosis drives the regulation of immune-inflammatory
reactions, which occur in response to microbes producing
anti-inflammatory signals affecting phagocytes at the site of
infection.10 Defective control of the inflammatory response in
this complex microenvironment can lead to the chronic, hyper-
inflammatory disease of periodontitis. Notably, Porphyromonas
gingivalis has been associated with inducing and propagating
this aberrant host response.11 The non-resolving hyper-
inflammatory response results in local tissue damage and
ultimately tooth loss. The disease is also associated with
several chronic inflammatory systemic diseases. P. gingivalis
reportedly impairs the host inflammatory response, which
underpins periodontal disease pathogenesis.12–14
A range of virulence factors are expressed by P. gingivalis,
including the important cysteine-proteases gingipains, which
may be arginine-specific (RgpA and RgpB) or lysine-specific
(Kgp). Gingipains play amajor role in the onset of inflammation
by multiple mechanisms including: modifying the complement
system; matrix metalloproteinase activity; neutrophil function;
periodontal tissue vascular structure and responses; the host
cytokine network and cell surface receptor levels.15 Notably,
gingipains have been shown to cleave key pattern recognition
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receptors,16,17 which have been shown to mediate recognition
and removal of AC.18 Previous work has now also demon-
strated that products of P. gingivalis may modulate AC
clearance via multiple changes at the apoptotic cell
surface.19 Here we address the hypothesis that gingipains
promote disease progression by acting to inhibit multiple
stages of the AC clearance process. We assess the effect of
gingipains on the ability of macrophages to identify AC,
interact with and remove AC and respond to resolve
inflammation. This study therefore provides novel insights
into potential mechanisms important in periodontitis
progression.
Results
Purification and characterisation of proteolytic enzymes
from P. gingivalis. Preliminary experiments to isolate
gingipains were undertaken using two strains of P. gingivalis
(strains W83 and HG66). Cultures were fractionated and the
presence of gingipain was assessed using an assay of
protease activity in membrane, culture supernatant and outer
membrane fractions (Figures 1a and b). These assays
revealed that both gingipain forms (Rgp and Kgp) were
released into culture supernatant at significantly higher active
amounts by strain HG66 compared with strain W83
(Figure 1a). Subsequently, culture supernatants from strain
HG66 were used as a source of both Rgp and Kgp and
the enzymes were purified using gel filtration and affinity
chromatography with Sephadex G-150 and arginine-Sephar-
ose. Following purification, cysteine protease activity was
confirmed using the specific inhibitor TLCK, which is specific
for trypsin-like proteases such as Kgp and Rgp (Figure 1b).
Molecular mass analysis (Figure 1c) of the purified proteins
indicated a single major band for Kgp and a double band for
Rgp of anticipated molecular mass of ≃60 kDa and ≃50 kDa,
respectively.20,21 Purification of gingipains was confirmed
using mass spectrometric analysis (Supplementary Table 1).
Lipopolysaccharide (LPS) contamination was assessed
within the purified gingipain fractions using the Limulus
Amoebocyte Lysate assay, which confirmed endotoxin
presence at levels 2.9 U/ml (RgpB) and 1.9 U/ml (Kgp).
Following successful purification of gingipains, the impact of
these important pathogen-derived enzymes on the removal of
AC was assessed.
Gingipains reduce expression of CD14, an apoptotic cell
clearance receptor. A range of phagocyte receptors have
been implicated in the recognition of AC and CD14, an
important innate immune component, has been identified as
a key tethering receptor for AC.22,23 Our previous studies
have demonstrated that the human monocyte cell line THP-1,
when differentiated, provides an effective model for studying
the role of macrophages (MØ) in AC clearance and to assess
the role of cytokines and other inflammatory mediators
released during this process.5,24,25 To understand the impact
of gingipains on the expression of important phagocyte
receptors, we examined a panel of innate immune receptors
on phagocytes before and after treatment with gingipains.
THP-1 cells treated with dihydroxyvitamin D3 (VD3) were
used as a model phagocyte, expressing high levels of CD14,
that is functional for the clearance of AC.5,24 MØ or primary
human neutrophils (NØ)were treatedwith purified RgpB or Kgp
and the expression of a panel of molecules (CD14, CD36,
ICAM-3 and CD91) known to mediate AC clearance was
assessed using indirect immunofluorescence and flow cyto-
metry (Figure 2a). Kgp specifically reduced the expression of
CD14, but not ICAM-3 or CD36, on the surface of both MØ and
NØ with 1 h of treatment. However, while Rgp also specifically
reduced CD14 expression on NØ with 1 h treatment, an
extended period of incubation was required to see the same
reduction on MØ (Figure 2b), a reduction that was not
associated with a loss of MØ viability (Supplementary
Figure 1). In addition, the rapid reduction in CD14 seen on
Kgp-treated MØ was rescued using the specific inhibitor TLCK
(Figure 2c), suggesting gingipains cleave CD14. Crucially, such
gingipain treatment of MØ did not induce detectable cytotoxicity
(Figure 2d). These data suggest that gingipains are capable of
specific cleavage of the apoptotic cell tethering receptor CD14,
data in agreement with previous reports.16,26,27
Figure 1 Determination of amidolytic activity and molecular weight of purified
proteolytic enzymes from P. gingivalis. Strains W83 or HG66 were grown and cultures
fractionated as described. Enzyme amidolytic activity was assessed (a) for Rgp
activity against Bz-L-Arg-pNA (left panel) and, for Kgp activity, against Z-L-LYS-pNA
(right panel) for: membrane-bound cell extract (black bar), cell-free culture
supernatant (white bar) and outer membrane fractions (grey bar). Statistical tests
compared differences between strains. Enzymes were purified using chromato-
graphy. (b) Compares the TLCK inhibition as a measure of cysteine protease activity
in the purified gingipains. (c) SDS-PAGE electrophoresis of P. gingivalis HG66 purified
Rgp and Kgp gingipain. Statistical analyses were conducted using ANOVA followed
by Bonferroni post hoc-test *Po0.05, **Po0.01, ***Po0.001. Data shown are
mean± S.E.M. of three independent experiments of log phase bacterial cultures
grown for 24 h (O.D. 600 nm)
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Gingipains inhibit the directional migration of phago-
cytes to AC. As previous results demonstrated specific and
rapid cleavage of CD14 by gingipains, we subsequently
assessed the impact of this on effective clearance of AC.
Here we assessed the impact of gingipain treatment on both
the migration of phagocytes towards dying cells and the
removal of cell corpses.
To consider the effect of gingipains on MØmigration, THP-1
MØ were treated initially with Kgp as it acts rapidly on MØ
receptors (Figure 2a) and then exposed to AC cultures
(primary NØ or Burkitt’s lymphoma (BL) cells) in a horizontal
Dunn chemotaxis chamber system. Previously, we have
shown that apoptotic BL cells serve as a relevant model to
study the binding and uptake by phagocytes5,22 and hence
were used as a positive control. Phagocyte migration was
recorded for 2 h at 37 °C using time-lapse video microscopy
(Figure 3). Phagocytes were clearly motile throughout the
assay period even in the absence of a putative attractant
(left panel, Figures 3a and c). However, when phagocytes
were exposed to apoptotic NØ (middle panel, Figure 3a) or
apoptotic B cells (middle panel, Figure 3c), rapid and
directional movement of MØ was evident. Kgp-treated MØ
continued to migrate, however, gingipain-treated phagocyte
migration towards AC was significantly reduced (right panel,
Figure 2 Purified gingipains cleave CD14 from the surface of macrophages and NØ. (a) Human primary NØ or THP-1 cell-derived MØ were treated with the indicated purified
gingipains for 1 h at 37 °C prior to indirect immunofluorescence staining for receptors/ligands implicated in apoptotic cell clearance. Fluorescence levels are shown as percentage
of cells positive for antigen (left) and mean fluorescence intensity (right). (b) THP-1 cell-derived MØ were treated with Rgp for up to 12 h at 37 °C prior to indirect
immunofluorescence staining for CD14 at the indicated times. Fluorescence levels are shown as percentage of cells positive for antigen and mean fluorescence intensity. (c) MØ
were treated with Kgp for 1 h in the presence or absence of the inhibitor TLCK prior to assessment of CD14 expression via flow cytometry. (d) Representative flow cytometric
analyses of THP-1-derived MØ or NØ treated with RgpB or Kgp for 1 h at 37 °C and stained with annexin V and propidium iodide to reveal cell viability. Flow data shown are
collected from at least 5000 events. Data presented are mean±S.E.M. of at least three independent experiments. Statistical analysis was performed using ANOVA followed by a
Bonferroni post hoc-test. **Po0.01; ***Po0.0001 compared with untreated cells
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Figures 3a and c). This was shown by a reduced forward
migration index for both apoptotic BL cells and primary
apoptotic NØ compared with untreated MØ migration towards
the AC (Figures 3b and d). Importantly, other measures of
migration (specifically velocity, accumulated distance and
Euclidean distance) were unaffected (Supplementary
Figure 2). Thus, treatment of MØ with Kgp, significantly
reduced only the directionality of MØ migration towards dying
cells, impairing effectiveMØ recruitment to dying cells. Further
studies employed a vertical migration system to address
further MØ migration following gingipain treatment. These
studies demonstrate that Rgp treatment also inhibits MØ
migration to apoptotic NØ (Figure 3e).
Gingipains inhibit the interaction of AC with MØ.
Inefficient removal of apoptotic NØ may result in significant
periodontal tissue damage if they are not cleared rapidly
by MØ.28
Figure 3 Gingipains inhibit macrophage migration towards AC. THP-1 cell-derived MØ were exposed to putative attractants in a horizontal or vertical migration assay. For the
horizontal assay (a–d), MØ were seeded to glass coverslips and treated or untreated with gingipains before loading to a Dunn horizontal chamber and exposed to putative
attractants (a–d). MØ migration was monitored for 2 h at 37 °C using time-lapse video microscopy. Migration of 40 cells per assay was measured using ImageJ and Ibidi
Chemotaxis and Migration Tool (V2.0). The MØ route of travel is shown by a line from the starting point (set at the cross hairs of the plots) to the final MØ position after 2 h (black
dot). The relative location of AC was at the top of the plot (black diamond). (a) Representative plots showing: left panel: untreated MØ (MØ) migration with control, cell-free
medium as putative attractant to reveal basal levels of MØ migration. Centre panel: untreated MØ (MØ) migration with apoptotic NØ as attractant. Right panel: Kgp-treated MØ
(Kgp-MØ) migration with apoptotic NØ as attractant. (b) Forward migration index (Y FMI) to quantify MØ migration in the direction of the putative gradient. (c) Representative plots
showing: left panel: untreated MØ (MØ) migration with control, cell-free medium as putative attractant to reveal basal levels of MØ migration. Centre panel: untreated MØ (MØ)
migration with apoptotic B cells as attractant. Right panel: Kgp-treated MØ (Kgp-MØ) migration with apoptotic B cells as attractant. (d) Forward migration index (Y FMI) to quantify
MØ migration in the direction of the putative gradient. (e) For the vertical migration assay, MØ (untreated or treated with gingipain) were seeded to a transwell above a lower well
containing secretome from apoptotic NØ and MØ migration to lower chamber assessed after 10 h by cell counting. Data shown in (b and d) are representative of four distinct
experiments with two replicates in each experiment. Statistical analysis was conducted using ANOVA followed by Bonferroni post hoc-test *Po 0.05, **Po0.01, ***Po 0.001
Gingipains, apoptotic cell removal and inﬂammation
SA Castro et al
4
Cell Death and Disease
Previous work has demonstrated the importance of CD14
as a tethering receptor for AC through the use of anti-CD14
mAbs22,23 or CD14-deficient animals.29 These studies
demonstrated that MØ CD14 binds to, as yet unidentified,
ligands at the surface of a wide range of AC. Given the
gingipain-mediated reduction in CD14 expression (Figure 2),
the impact of gingipain treatment on AC removal was
assessed. THP-1 MØ were co-cultured with AC (BL or NØ)
and the level of AC–MØ interaction scored and compared with
that of equivalent gingipain-treated MØ. Photomicroscopy
revealed evidence of MØ interacting with AC (Figure 4a),
where ‘Interaction’ is defined as either binding or phagocy-
tosed AC, irrespective of the number of AC bound or
internalised. When this level of interaction was scored, it was
clear that the percentage of MØ interacting with apoptotic NØ
cells was significantly reduced following gingipain treatment of
MØ (left panel, Figure 4b). This effect was more evident when
scoring the mean number of AC per MØ (right panel,
Figure 4b). However, when apoptotic BL cells were used,
gingipains did not cause a decrease in interaction (left panel,
Figure 4c), a consequence of their failure to inhibit completely
the interaction of apoptotic BL cells with MØ. A clear gingipain
inhibitory effect was however noted when the mean number of
AC per MØ was scored (right panel, Figure 4c). In these
assays, both gingipains assayed reduced AC clearance
indicating that this effect is not mediated solely through the
reduced expression of CD14 as, in this time frame, only Kgp
reduced MØ CD14 surface levels. Importantly, gingipain
treatment had no significant effect on MØ viability
(Supplementary Figure 1).
TNF-α production by MØ in response to P. gingivalis LPS
is inhibited by AC or their derived secretomes. AC
clearance is known for its non-phlogistic phenotype and AC
have been reported widely to exert potent anti-inflammatory
effects to promote resolution of inflammation.30–32 To explore
the nature of the inflammatory responses of MØ in the
presence of AC, MØ production of TNF-α in response to LPS
from P. gingivalis was assessed in the presence or absence of
apoptotic NØ or apoptotic BL cells. Additionally, AC are known
to release a range of factors (the secretome), including
apoptotic cell-derived extracellular vesicles, into their super-
natant that can modulate apoptotic cell clearance.3,5,6,33
P. gingivalis LPS was capable of inducing strong TNF-α
production that was inhibited following MØ incubation with
either AC or their derived secretome (Figure 5a). This
suggests that it is possible for AC to exert a dominant
anti-inflammatory effect on TNF-α production induced by the
pathogen P. gingivalis.
Gingipains induce TNF-α production by MØ that is not
inhibited by AC. When considering the effects of gingipains
on the ability of AC to modulate inflammation, we noted that
gingipain treatment alone of MØ was sufficient to induce
TNF-α production in just 1 h (Figure 5b). This effect was
observed with two different models of THP-1-derived MØ
(VD3 or PMA/VD3) that are known to have profoundly
different sensitivity to LPS (Supplementary Figure 3).24
Notably, the responses of these cells to gingipain prepara-
tions were similar, which indicates that the detected
inflammatory response was not due to LPS contamination
of gingipain preparations. This observation raises the
possibility that chronic inflammation may derive from the
direct action of gingipains on pro-inflammatory responses
and not simply through indirect effects (e.g., through inhibited
AC removal).
Given this intrinsic induction of inflammation, we were
interested to consider the ability of AC or their derived
Figure 4 Gingipain treatment of MØ inhibits interaction of MØ with apoptotic NØ
and apoptotic BL cells. THP-1-derived MØ were treated or untreated with gingipains
prior to co-culture with AC for 1 h. (a) Photomicrographs of Jenner–Giemsa stained
untreated or gingipain-treated THP-1 cell-derived MØ interacting with apoptotic BL
cells (AC BL) or primary apoptotic NØ (AC NØ). Untreated THP-1 MØ showing
tethering and phagocytosing of apoptotic BL (upper left panel) and NØ (lower left
panel). Gingipain-treated THP-1 MØ (Rgp: centre panels; Kgp: right panels) showing
interaction with fewer apoptotic BL cells (upper panels) and NØ (lower panels) with an
increased number of unbound/non-phagocytosed, extracellular AC (arrows). THP-1
MØ can be seen in light blue and AC are stained a characteristic intense blue. Arrows
in the lower right panel indicate primary apoptotic NØ not taken up by phagocytes. All
images were taken at ×40 magnification. (b) Histograms showing the percentage of
MØ interacting (binding or phagocytosing) with apoptotic NØ cells (left panel) or the
mean number of AC per MØ (right panel) with or without gingipain treatment of MØ or
(c) histograms showing the percentage of MØ interacting (binding or phagocytosing)
with apoptotic BL cells (left panel) or the mean number of AC per MØ (right panel)
with or without gingipain treatment of MØ. Data shown are mean±S.E.M. of at least
three independent experiments. Statistical analysis was conducted using ANOVA
followed by Bonferroni post hoc-test: ***Po0.001
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secretome to modulate this response. In line with the previous
experiments (Figure 5a), MØ were treated with AC or
secretome prior to addition of the inflammatory stimulant
(Rgp or Kgp) and analysis of TNF-α production. Although AC
or their derived secretome inhibited LPS-induced TNF-α
production (Figure 5a), these cells or their secretomes had
no ability to reduce gingipain-induced inflammation
(Figure 5c). These data raise the possibility that gingipains
induce local tissue inflammation that is resistant to the
usual mechanisms that aim to promote the resolution of
inflammation.
Taken together, the data presented here support the notion
that the key gingival pathogen P. gingivalis promotes
inflammation by different mechanisms. These include inhibi-
tion of apoptotic cell clearance via the action of gingipains on
apoptotic cell clearance mechanisms including CD14 and
through the direct gingipain induction of inflammation that is
recalcitrant to the usual inhibitory effects of apoptosis.
Discussion
Previous studies have shown that a major factor in periodontal
disease is the significant proteolytic activity of P. gingivalis
including the three gene products encoding gingipains.26,34,35
In the present study, we characterise two gingipains (Kgp and
Rgp) for their ability to modulate a key event in the resolution of
inflammation, that is, the rapid clearance of AC. For the first
time, we take amore complete approach to the in vitro analysis
of AC clearance and consider the impact of gingipains not only
on the binding and phagocytosis of AC but also on the
migration of phagocytes towards cell corpses and their
immune modulation by dying cells. Migration of phagocytes
to AC is a key event in the clearance process that is often
overlooked in in vitro assays of AC removal.
Here we report isolation of Kgp and Rgp from P. gingivalis
using established methods. Our analyses of protease activity
are consistent with successful isolation in line with previous
work.20,21,34,36
Periodontal disease is a chronic, non-resolving inflamma-
tory condition characterised by persistent neutrophilic activity.
During acute inflammation, neutrophil recruitment is followed
by neutrophil apoptosis and rapid non-phlogistic clearance of
AC by MØ. The course of AC clearance is a complex,
multistage process that begins with AC communicating their
presence via their secretome (i.e., apoptotic cell-derived
extracellular vesicles and soluble factors), which act as ‘find
me’ signals to phagocytes (reviewed in ref. 37). Following
phagocyte recruitment, an array of ligands, receptors and
bridging molecules effect binding and removal of cell corpses
(reviewed in ref. 37). Additionally, immune modulation of the
microenvironment supports pro-resolution and anti-
inflammatory effects.38 Given the importance of AC clearance
to the control of inflammation, we sought to define the impact
of gingipains on these processes to understand better the
defects that may contribute to periodontal disease.
The recruitment of phagocytes to sites of cell death is an
essential process to promote the effective resolution of
inflammation. Here we show that MØ treated with gingipains
are less direct in their migration towards dying cells. Although
our data suggest a correlation between CD14 loss and
inhibited migration following protease treatment, this does
not identify formally a causal relationship. Indeed, Rgp
profoundly inhibited MØ migration at time points when CD14
cleavage was low. Thus, the precise molecular mechanism by
which this gingipain-mediated inhibition is effected remains to
be fully elucidated, however, it remains a possibility that this is
mediated through CD14. Previous work33 suggests CD14 is
not required for ‘sensing’ dying cells though the study did not
assess directionality as was studied here. Additionally, recent
reports of CD14-mediated leukocyte migration39,40 suggest
the CD14 role in macrophage migration towards AC deserves
close attention. Further studies are required to define
alternative mechanisms of action, possibly mediated through
GPCR chemokine receptors, for example, proteinases from P.
gingivalis cleave the human C5a receptor.41 Thus CX3CR1,
which promotes migration to AC, or cleavage of receptors for
Figure 5 Apoptotic NØ inhibit LPS-induced but not gingipain-induced TNF-α
production (a) THP-1-derived MØ (VD3/PMA) were co-cultured with AC (NØ or BL) or
their derived secretomes for 18 h prior to the addition of LPS from P. gingivalis. After
4 h stimulation, TNF-α production was assessed using ELISA. (b) THP-1-derived MØ
(black: VD3-differentiated THP-1; grey: VD3/PMA-differentiated THP-1) were treated
with the indicated gingipain for 1 h immediately prior to ELISA for produced TNF-α.
(c) THP-1-derived MØ (VD3/PMA) were co-cultured with AC (NØ or BL) or their
derived secretomes for 18 h prior to treated with gingipain from P. gingivalis to ELISA
for produced TNF-α. Data shown are mean±S.E.M. for three independent
experiments. Statistical analysis was conducted using ANOVA followed by Bonferroni
post hoc-test: **Po0.01, ***Po0.001
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secretome factors (e.g., apoptotic cell-derived extracellular
vesicles) that also promote migration3,5,6,33 may be likely
targets for gingipains. Irrespective of the mechanism, any
reduction in directional migration is likely to impact on the
course of inflammation in periodontitis. This may also be a
mechanism bywhich systemic effects of gingipains occur, with
poorly controlled MØ recruitment throughout the body.
Here we demonstrate gingipains cleave MØ CD14 in line
with previous studies.16,26 Treatment with LPS alone had no
such effect. We demonstrate that Kgp cleaves CD14 more
rapidly than Rgp, in agreement with previous observations of
relative activity of gingipains.42 This may be due to the
presence of a hemagglutinin/adhesion domain present in Kgp
but not RgpB.20 Our data correlate with previous clinical
research reporting less CD14 expression in chronic period-
ontitis samples than in healthy periodontal gingival samples,
supporting the notion that CD14 expression correlates with
periodontal health.43 Such cleavage within 1 h of protease
exposure raises the potential for rapid onset of detrimental
effects associated with CD14 loss. Additionally, it is highly
likely that other receptors may be cleaved though we detected
no reduction of ICAM-3, CD36 or CD91. This is surprising,
given the presence of putative gingipain cleavage sites within
the protein sequences but highlights that accessibility of
cleavage sites may be key in determining whether any given
molecular target can be cleaved. Interestingly, we demon-
strate also that neutrophil CD14 is cleaved suggesting ligands
on dying leukocytes may be affected in the periodontal
microenvironment. Previous work suggests that loss of the
CD31 from NØ treated with Rgp but not Kgp can promote NØ
removal byMØ.19 Although we demonstrate CD14 cleavage, it
is likely other ligand/receptors are also cleaved and a full
assessment of all molecular targets would be worthwhile.
Themechanisms by which dying cells are removed exhibit a
high level of redundancy.44 However, CD14 is a key tethering
receptor for AC22 that is non-redundant as CD14-deficient
animals carry an increase in persistent cell corpses.29
Interestingly, Truman et al.33 suggested that MØ CD14 may
be upregulated during migration towards AC as they become
increasingly competent to remove cell corpses. Taken
together, it seems likely that the rapid cleavage of CD14 and
consequent failure for efficient AC clearance will promote
defective control of inflammation in periodontitis. Cell persis-
tence of hyperactive NØ from the gingival crevice of period-
ontitis patients will drive collateral tissue damage45 and failed
removal of activated NØ may cause tissue destruction as they
undergo secondary necrosis, leading to periodontal tissue
damage.28 Our research correlates also with previous studies
highlighting the level of necrotic cell death, likely as a result of
failed clearance, in NØ;46,47 in addition to their release of
destructive hydrolytic enzymes48–50 found in gingival crevicu-
lar fluid from the active phase of periodontitis. These support
the notion that failure to uptake apoptotic NØ following
gingipain cleavage of specific receptors, for example, CD14,
will drive necrosis resulting in connective tissue matrix
destruction in periodontitis.
It is also noteworthy that previous studies have also shown
that CD14 cleavage, via human neutrophil elastase, can inhibit
clearance of AC51 though it was the potential for protease
inhibition, via delivery of inhibitors, to recover effective AC that
provides a clear therapeutic rationale within periodontal
disease. Furthermore, this previous work highlights the likely
significance of CD14 cleavage on phagocyte cellular function.
The balance of pro-inflammatory and pro-resolution/anti-
inflammatory cellular responses will decide the nature and
duration of an inflammatory response in the tissue. It is well
established that AC exert strong anti-inflammatory effects30,31
and that the onset of inflammation initiates events that
ultimately promote resolution.38 Here we assessed the ability
of apoptotic human NØ and their derived secretome to inhibit
inflammation induced byP. gingivalis LPS. In linewith previous
reports using E. coli LPS,24,30–32 we noted a strong anti-
inflammatory effect suggesting dying cells, within a period-
ontium infected with P. gingivalis, ought to be capable of
promoting resolution of inflammation. However, we noted that
gingipain treatment of MØ alone was sufficient to induce
inflammatory responses. Recently, gingipains have been
reported to promote monocyte inflammatory responses52 via
protease-activated receptors and Toll-like receptors/NOD-like
receptor ligation.53 Furthermore, gingipains have been shown
to cleave protease-activated receptors on oral keratinocytes
resulting in innate immune responses.54 Kgp is capable of
generating a keratin fragment from epithelial cells, which
induces inflammatory responses in epithelial and fibroblast
cells.55 Importantly, this gingipain-induced inflammation was
not modulated by AC suggesting that gingipain-induced
inflammation may be dominant within the periodontal micro-
environment, possibly as a result of loss of key immune
modulatory receptors and/or induction of potent inflammatory
responses. This may be responsible for driving a continued
inflammatory response.
Although our study has focused on the impact of gingipains
on the sensing and handling of dying leukocytes, it is important
to note that CD14 is an innate immune receptor and the
modulation of CD14, and other such receptors, by gingipains
is likely an immune evasion strategy of the pathogen.16 Thus,
when considering the complete periodontal environment, one
should also assess the impact of gingipain treatment on
phagocyte migration towards P. gingivalis and subsequent
immune clearance.
Taken together, we propose that gingipains can have
profound and varied effects on the resolution of inflammation.
The inhibition in directional migration of MØ towards dying
cells, coupled with reduced efficiency of apoptotic cell
clearance and induction of dominant pro-inflammatory
responses by gingipains, will promote the chronic inflamma-
tory milieu characteristic of the progressive and debilitating
periodontal disease. Thus, we support gingipains as an
attractive target for therapeutic intervention.
Materials and Methods
Cell isolation, cell lines and culture. Peripheral blood NØ were collected
from healthy donors using EDTA - BD vacutainers and isolated using a two-step
discontinuous Percoll column (1.079 and 1.098 g/ml) with centrifugation (150 × g for
8 min, followed by 1200 × g for 10 min without braking). Isolated NØ were washed
and resuspended in PBS supplemented with 1.5% (w/v) glucose and cations (1 mM
MgCl2, 1.5 mM CaCl2) prior to assessment of NØ purity or in RPMI 1640 medium
containing 0.15% (w/v) BSA (‘NØ medium’) for generation of AC. Human monocytic
leukaemia THP-1 and EBV-positive BL.56 Mutu cells were cultured in ‘complete’
RPMI 1640 (RPMI containing 10% (v/v) foetal calf serum, 2 mM L-glutamine,
100 IU/ml penicillin, 100 mg/ml streptomycin (PAA Laboratories Ltd Yeovil,
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Somerset, UK)). The cells were cultured at 37 °C in a humidified environment at 5%
(v/v) CO2.
THP-derived macrophage-like cells were produced by differentiation over 48–72 h
with VD3 (100 nM) or both VD3 and 250 nM phorbol ester (PMA; Sigma, Dorset, UK)
as described previously.24 Where appropriate, MØ were treated with gingipain (5 μg/
ml of purified isolated enzyme) in serum-free RPMI medium for 1 h at 37 °C prior to
addition of complete RPMI and further analyses.
Bacterial strains and growth conditions. P. gingivalis ATCC 33277,
W83 and HG66 was kindly provided by the Periodontal Research Group, School of
Dentistry, University of Birmingham, UK. Bacteria were grown in liquid medium
(Fastidious Anaerobe Broth, LAB M, Lancashire, UK) containing 5% sheep blood
agar containing, per litre, 10.0 g yeast extract, 5 mg haemin, 0.5 mg vitamin K1,
500 mg L-cysteine were incubated at 37 °C in an anaerobic atmosphere (miniMACS
anaerobic workstation; Don Whitley Scientific, UK) of 10% H2, 10% CO2 and 80%
N2. Growth of the P. gingivalis strains was monitored spectrophotometrically over a
period of 72 h (optical density at 600 nm) and samples of the cultures were Gram
stained to confirm their purity.
Isolation, purification and identification of gingipains. Gingipains
from HG66 were isolated according to the method described by Pike et al.21 The
crude extract of outer membrane fractions from P. gingivalis strain W83 were
prepared according to ref. 57. Enzyme activity and molecular weight of the purified
proteins were determined as described by Pike et al.21
Following bottom-up proteomics approach,58 purified gingipains were positively
identified using LC-MS/MS (QExactive ThermoFisher, Rugby, UK). Acquired data
were searched against SwissProt database using Sequest search engine. For both
gingipains, more than 30 peptides with at least two unique sequences were identified,
thereby assuring at least 28% of total protein coverage and providing the highest
identification scores (Score41000) (Table 1 in Supplementary Material).
Apoptosis induction and quantification. Human primary NØ and the
human BL cell line (Mutu) were induced to apoptosis either by UV-B irradiation
using a Chromata-vue C71 light box and UVX radiometer (UV-P Inc, Uplands,
CA, USA) or exposure to proteolytic enzymes from P. gingivalis. BL cells were
resuspended in complete RPMI medium and exposed to 50 mJ/cm2. Peripheral
blood neutrophils resuspended in 0.15% (w/v) bovine serum albumin (Sigma-
Aldrich, Poole, Dorset, UK), 100 mg/ml penicillin and 100 mg/ml streptomycin were
cultured at 37 °C for 16 h and used as a source of AC. Where apoptotic cell-
secretome was used, apoptotic cell cultures were centrifuged at 2000 × g for 20 min
to remove cell and large debris and the supernatant was used. Apoptosis was
quantified using annexin V-FITC and propidium iodide (eBioscience, High
Wycombe, UK) staining according to the manufacturer’s instructions. Briefly, cells
(5 × 105–1 × 106) were washed with ‘binding buffer’ (10 mM HEPES, 150 mM NaCl
and 2.5 mM CaCl2 in water) and resuspended in ‘binding buffer’ containing annexin
V (1 μl per 200 000 cells) and incubated on ice for 5 min. Incubated cells were
either washed with buffer and/or added directly to propidium iodide to a final
concentration of 20 μg/ml and analysed immediately by flow cytometry (FC500;
Beckman Coulter, Fullerton, CA, USA).
Surface receptor expression on MØ and NØ. THP-1 cells differentiated
with VD3 for 48–72 h were exposed to purified gingipains RgpB or Kgp (from strain
HG66) at various concentrations and time periods. Cells were washed with PBS
containing 1% (w/v) BSA and stained with anti-mouse CD14 (clone 63D3) followed
by anti-mouse IgG FITC (Sigma-Aldrich) and receptor expression was determined
by flow cytometry. The percentage of cells positive for antigen and the mean
fluorescence intensity were analysed using FlowJo analysis software (FlowJo, OR,
USA).
Horizontal migration assay. The phagocytic cells used were 48 h THP-1/
VD3 differentiated MØ cultured on a coverslip in a six-well plate. DUNN chamber
glass slides (Hawskley, Lancing, Sussex, UK. DCC100) were used according to the
manufacturer’s instructions. Briefly, a coverslip carrying THP-1-derived MØ was
placed on the chamber containing macrophage medium (Invitrogen Corp., Paisley,
UK) and 100 μl of chemoattractant was loaded to the outer well before the chamber
was sealed with wax. The cell behaviour was recorded at 37 °C for 2 h using a fully
motorised Zeiss Axiovert 200M fluorescence microscope (Carl Zeiss Ltd., Welwyn
Garden City, UK) and images collected every 10 min by a Hamamatsu Orca camera
driven by Volocity (Perkin-Elmer, Cambridge, UK). Cell tracking was evaluated using
ImageJ followed by the chemotaxis and migration tool software (version 2.0; Ibidi
GmbH, Martinsried, Germany).
Vertical migration assay. MØ migration towards AC was assessed using the
Cell-IQ tracking system (CM Technologies, Tampere, Finland). THP-1 stimulated
with VD3 (48 h) were used as phagocytes. To set up the experiment, 700 μl per well
of AC (1 × 106) or their derived secretomes were added to the wells of a 24-well
transwell companion plate (Falcon, Corning, Amsterdam, the Netherlands). A
transwell with 8.0 μm pore PET membranes (Falcon, Corning) was subsequently
placed in each well 300 μl of MØ (5 × 105) were added. Migration of MØ from the
upper transwell chamber to the lower well was recorded for 10 h using the Cell-IQ
system. Migrated cells were detected by their appearance on the base of the lower
well. Data were analysed using the Cell-IQ software.
Assay of apoptotic cell–MØ interaction. THP-1-derived MØ (THP-1/
PMA) were cultured on four-well glass slides (Hendley (Essex) Ltd, Loughton, UK).
AC were induced to apoptosis and after overnight incubation were washed via
centrifugation into fresh RPMI containing 0.2% w/v BSA (Sigma-Aldrich). AC were
co-cultured with MØ at a ratio of 100 : 1 for 1 h at 37 °C in RPMI containing 0.2% w/
v BSA (Sigma). Unbound cells were removed by washing in cold PBS and slides
were fixed in methanol prior to staining with Jenner–Giemsa. Interaction was scored
as the percentage of MØ that had AC associated, where the AC could be surface
bound or internalised. Where appropriate, the mean number of AC per MØ was also
enumerated.
Measurement of TNF-α. TNF-α levels were measured in supernatants of
macrophage exposed to purified gingipains incubated for 1 h at 37 °C.
Subsequently, the reaction was inactivated by washing the cells with PBS
containing 1% (w/v) BSA prior to challenge with LPS from P. gingivalis (InvivoGen,
San Diego, CA, USA) for 4 h in the presence of AC. TNF-α was determined by
ELISA using matched-pair capture and biotinylated detection antibodies (R&D
Systems, Abingdon, UK). Bound detection Ab was detected using streptavidin-HRP
followed by colorimetric SigmaFAST OPD assay (Sigma).
Statistical analysis. Data were analysed using Graphpad (La Jolla, CA, USA)
from at least three independent experiments unless otherwise stated and presented
as the mean±S.E.M.
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